Perioperative Glycemic Control in Plastic Surgery: Review and Discussion of an Institutional Protocol.
Perioperative hyperglycemia is a well-known risk factor for surgical morbidity such as wound healing, infection, and prolonged hospitalization. This association has been reported for a number of surgical subspecialties, including plastic surgery. Specialty-specific guidelines have become increasingly available in the literature. Currently, glucose management guidelines for plastic surgery are lacking. Recognizing that multiple approaches exist for perioperative glucose, protocol-based models provide the necessary structure and guidance for approaching glycemic control. In this article, we review the influence of diabetes on outcomes in plastic surgery patients and propose a practical approach to perioperative blood glucose management based on current Endocrine Society and Mayo Clinic institutional guidelines.
From the Departments of Anesthesiology and Surgery, Mayo Clinic Florida, Jacksonville, FL, USA.
John D
JD
Dortch
From the Departments of Anesthesiology and Surgery, Mayo Clinic Florida, Jacksonville, FL, USA.
Dustin L
DL
Eck
From the Departments of Anesthesiology and Surgery, Mayo Clinic Florida, Jacksonville, FL, USA.
Beth
B
Ladlie
From the Departments of Anesthesiology and Surgery, Mayo Clinic Florida, Jacksonville, FL, USA.
Sarvam P
SP
TerKonda
D001786:Blood Glucose; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control*; D019990:Perioperative Care / Q000379:methods*; D011183:Postoperative Complications / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D013518:Surgery, Plastic / Q000009:adverse effects*
D001786:Blood Glucose